Update: Enhertu Approved In China For Her2-Mutant Metastatic Nsclc
AstraZeneca's Enhertu has been conditionally approved in China as a therapy for HER2-mutant metastatic non-small cell lung cancer.
All business news as they happen.
AstraZeneca's Enhertu has been conditionally approved in China as a therapy for HER2-mutant metastatic non-small cell lung cancer.
Ackermans & van Haaren (AvH) has committed €5 million to a €15 million private placement organized by agricultural technology company Biotalys NV (Euronext…
Randstad appoints Jesus Echevarria as COO; Chris Heutink departs after 30 years.
UCB has received FDA approval for new single-injection device options of BIMZELX® (bimekizumab-bkzx) in 320 mg doses, expanding administration choices for patients with…
Givaudan Taste & Wellbeing breaks ground on a new production facility in Indonesia, investing in expanding manufacturing in Southeast Asia for various food…
A1 Group announces SkyShowtime launch in Bulgaria, Serbia, Croatia, Slovenia, and North Macedonia, starting with A1 Bulgaria.
JPMorgan Chase released its third-quarter 2024 financial results. The firm has $4.2 trillion in assets and $346 billion in stockholders' equity. JPMorgan Chase…
ArcelorMittal sent an email to Boris about Nippon Steel selling its interest in Calvert to ArcelorMittal. The email includes links to a press…
Stellantis has announced several significant executive appointments, realigning its leadership across key markets and reinforcing its focus on growth and operational efficiency.
Weekly NEAR ecosystem newsletter featuring updates on NEAR, details about the hackathon, and various events and announcements related to NEAR's ecosystem and developments.…